Makis Health - by William Makis (Cancer Researcher)

Makis Health - by William Makis (Cancer Researcher)

NEWS: New cancer injection eliminated tumors in some patients - how to analyze bogus Cancer Drug Industry news

William Makis's avatar
William Makis
Jun 01, 2026
∙ Paid

ARTICLE LINK:

By:Alex Karpa

Updated: June 01, 2026 at 6:15AM EDT

A promising new cancer treatment, delivered through a simple injection under the skin, has demonstrated significant tumour shrinkage in patients with recurrent and/or metastatic head and neck cancer.

Scientists from the Institute of Cancer Research (ICR) presented their findings from the research, known as the OrigAMI-4 trial, at the American Society of Clinical Oncology’s (ASCO) annual meeting Sunday.

The jab, called amivantamab, was given to people who had stopped responding to standard treatments.

Research shows the injection of amivantamab shrank tumours in 43 of the 102 patients, including 15 whose tumours disappeared completely.

Experts say the results of this clinical trial are promising.

Amivantamab is a targeted cancer treatment designed to block several of the signals that help cancer cells grow and spread. It is made by Johnson & Johnson and is already used to treat certain types of lung cancer.

ANALYSIS:

Always look at…

User's avatar

Continue reading this post for free, courtesy of William Makis.

Or purchase a paid subscription.
© 2026 William Makis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture